Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

cGAS-activating nanoassemblies for solid tumors

December 7, 2022 8:45 PM UTC

Nanoassemblies that release manganese ions and a topoisomerase inhibitor into the tumor microenvironment could help treat solid tumors by activating cGAS-STING signaling in dendritic cells and cancer cells.

The nanoassemblies consisted of albumin proteins modified with dendritic cell-targeting mannose groups and carrying manganese ions that enhance cGAS activity, cross-linked with tumor-targeting ferritin nanocages delivering a topoisomerase inhibitor tool compound that induces immunogenic cell death and release of cGAS-activating double-stranded DNA; the complex dissociates into monodispersive units in the acidic tumor microenvironment...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article